The aim of the study is to analyze all completely excised BCCs in the head and neck region with regard to age, sex, personal and familial history, skin type, tumor localization and size, histopathological subtype of tumor, reconstruction method, and recurrence rates. Incompletely excised BCCs were not included in this study since incomplete excision is the most important preventable risk factor for recurrence. In 320 patients, 331 lesions were retrospectively evaluated by dividing into the following 8 subunits: scalp, frontotemporal, orbital, nose, cheek, auricula, perioral, and chin-neck area. Most of the patients were in 60–70 age group (34.7%). The nose (32.3%) was the most common site of presentation. Clinically, all lesions and, histopathologically, most of the lesions (42.2%) presented were of the nodular type. All cases of recurrence after complete excision ( , 2.7%) were located in the median parts of the head and neck region and were mainly diagnosed histopathologically as sclerotic and micronodular. Even though completely excised, head and neck region BCCs, especially which are more prone to recurrence due to anatomical and histopathological properties, should be more closely monitored in order to decrease morbidity and health care costs. 1. Introduction Basal cell carcinoma (BCC) is the most common type of skin cancer in the head and neck region. The incidence of BCC is on the rise, and it represents approximately 65% of all skin carcinomas [1–3]. BCC is not usually life threatening, unlike malignant melanoma, but it is locally invasive and may lead to considerable morbidity and complications [4]. BCC is the most frequent tumor type among the US population and also has a strongly rising incidence in Europe. Although, the incidence of BCC in Turkey is not accurately known, we think that there is a rise in the number of patients who are admitted to medical facilities [2]. With the increase in the incidence of BCC, even though mortality is relatively low, the morbidity and treatment-related costs represent a significant burden to health care systems. Treatment options include medical and surgical modalities. The first therapy of choice is generally surgical excision, with safe surgical margins. Recurrence is more common, especially with positive peripheral margins and certain types of BCC, like morpheaform forms. Recurrent BCC tends to be biologically more aggressive than primary lesions [1]. Positive surgical margins in primary BCC excisions in the head and neck region were reported to be 3–20% in the literature [5]. Recurrence rates in
References
[1]
L. Sartore, L. Lancerotto, M. Salmaso et al., “Facial basal cell carcinoma: analysis of recurrence and follow-up strategies,” Oncology Reports, vol. 26, no. 6, pp. 1423–1429, 2011.
[2]
Y. O. Tiftikcio？lu, O. Karaaslan, H. M. Aksoy, B. Aksoy, and U. Ko？er, “Basal cell carcinoma in Turkey,” The Journal of Dermatology, vol. 33, no. 2, pp. 91–95, 2006.
[3]
A. W. Wilson, G. Howsam, V. Santhanam et al., “Surgical management of incompletely excised basal cell carcinomas of the head and neck,” British Journal of Oral and Maxillofacial Surgery, vol. 42, no. 4, pp. 311–314, 2004.
[4]
U. Leiter and C. Garbe, “Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight,” Advances in Experimental Medicine and Biology, vol. 624, pp. 89–103, 2008.
[5]
O. S. Janjua and S. M. Qureshi, “Basal cell carcinoma of the head and neck region: an analysis of 171 cases,” Journal of Skin Cancer, vol. 2012, Article ID 943472, 4 pages, 2012.
[6]
D. Farhi, N. Dupin, A. Palangié, A. Carlotti, and M.-F. Avril, “Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases,” Dermatologic Surgery, vol. 33, no. 10, pp. 1207–1214, 2007.
[7]
V. Smith and S. Walton, “Treatment of facial basal cell carcinoma: a review,” Journal of Skin Cancer, vol. 2011, Article ID 380371, 7 pages, 2011.
[8]
H. M. Gloster Jr. and K. Neal, “Skin cancer in skin of color,” Journal of the American Academy of Dermatology, vol. 55, no. 5, pp. 741–760, 2006.
[9]
H. P. Soyer, D. S. Rigel, and E. M. T. Wurm, “Actinic keratosis, basal cell carcinoma and squamous cell carcinoma,” in Dermatology, J. L. Bolognia, J. L. Jorizzo, and J. V. Schaffer, Eds., pp. 1773–1793, Elsevier Saunders, Beijing, China, 2012.
[10]
K. Seretis, V. Thomaidis, A. Karpouzis, D. Tamiolakis, and I. Tsamis, “Epidemiology of surgical treatment of nonmelanoma skin cancer of the head and neck in Greece,” Dermatologic Surgery, vol. 36, no. 1, pp. 15–22, 2010.
[11]
S. Cho, M.-H. Kim, K.-K. Whang, and J.-H. Hahm, “Clinical and histopathological characteristics of basal cell carcinoma in Korean patients,” Journal of Dermatology, vol. 26, no. 8, pp. 494–501, 1999.
[12]
J. J. Rippey, “Why classify basal cell carcinomas?” Histopathology, vol. 32, no. 5, pp. 393–398, 1998.
[13]
R. Betti, E. Inselvini, M. Carducci, and C. Crosti, “Age and site prevalence of histologic subtypes of basal cell carcinomas,” International Journal of Dermatology, vol. 34, no. 3, pp. 174–176, 1995.
[14]
S. Boi, M. Cristofolini, R. Micciolo, E. Polla, and P. D. Palma, “Epidemiology of skin tumors: data from the cutaneous cancer registry in Trentino, Italy,” Journal of Cutaneous Medicine and Surgery, vol. 7, no. 4, pp. 300–305, 2003.
[15]
F. Revenga Arranz, J. F. Paricio Rubio, M. M. Vázquez Salvado, and V. del Villar Sordo, “Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998–2000: a hospital-based survey,” Journal of the European Academy of Dermatology and Venereology, vol. 18, no. 2, pp. 137–141, 2004.
[16]
Y. Scrivener, E. Grosshans, and B. Cribier, “Variations of basal cell carcinomas according to gender, age, location and histopathological subtype,” British Journal of Dermatology, vol. 147, no. 1, pp. 41–47, 2002.
[17]
D. Czarnecki, N. Collins, C. Meehan, T. O'Brien, S. Leahy, and C. Nash, “Basal-cell carcinoma in temperate and tropical Australia,” International Journal of Cancer, vol. 50, no. 6, pp. 874–875, 1992.
[18]
M. T. Bastiaens, J. J. Hoefnagel, J. A. Bruijn, R. G. J. Westendorp, B. J. Vermeer, and J. N. B. Bavinck, “Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumors,” Journal of Investigative Dermatology, vol. 110, no. 6, pp. 880–884, 1998.
[19]
M. Almahroos and A. K. Kurban, “Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations,” Skinmed, vol. 3, no. 1, pp. 29–35, 2004.
[20]
R. W. Griffiths, S. K. Suvarna, and J. Stone, “Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 60, no. 1, pp. 41–47, 2007.
[21]
D. J. Wolf and J. A. Zitelli, “Surgical margins for basal cell carcinoma,” Archives of Dermatology, vol. 123, no. 3, pp. 340–344, 1987.
[22]
N. Jallali, “Loupe magnification reduces the incidence of incomplete excision of basal cell carcinoma,” Plastic and Reconstructive Surgery, vol. 113, no. 6, pp. 1887–1888, 2004.
[23]
L. A. E. Sussman and D. F. Liggins, “Incompletely excised basal cell carcinoma: a management dilemma?” Australian and New Zealand Journal of Surgery, vol. 66, no. 5, pp. 276–278, 1996.
[24]
R. W. Griffiths, S. K. Suvarna, and J. Stone, “Do basal cell carcinomas recur after complete conventional surgical excision?” British Journal of Plastic Surgery, vol. 58, no. 6, pp. 795–805, 2005.
[25]
B. K. Goh, P. Ang, Y. J. Wu, and C. L. Goh, “Characteristics of basal cell carcinoma amongst Asians in Singapore and a comparison between completely and incompletely excised tumors,” International Journal of Dermatology, vol. 45, no. 5, pp. 561–564, 2006.
[26]
J. D. Richmond and R. M. Davie, “The significance of incomplete excision in patients with basal cell carcinoma,” British Journal of Plastic Surgery, vol. 40, no. 1, pp. 63–67, 1987.
[27]
D. P. Goldberg, “Assessment and surgical treatment of basal cell skin cancer,” Clinics in Plastic Surgery, vol. 24, no. 4, pp. 673–686, 1997.
[28]
R. Betti, S. Menni, G. Radaelli, C. Bombonato, and C. Crosti, “Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas,” Journal of Dermatology, vol. 37, no. 7, pp. 611–616, 2010.
